FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

PD-Rx Pharmaceuticals Losartan Potassium Recall

Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Okla…

PD-Rx Pharmaceuticals, Inc. · Oklahoma City, OK

Risk level
Class II
Reported by FDA
May 5, 2021
Recall ID
D-0341-2021
Check your lot numberHow we source this data

Summary

PD-Rx Pharmaceuticals recalled Losartan Potassium starting Mar 8, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0341-2021 on May 5, 2021. Reason: CGMP deviation: Product found to contain trace amounts of NMBA. Status: Terminated.

Why it was recalled

CGMP deviation: Product found to contain trace amounts of NMBA

Product description

Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets NDC: 43063-854-60; b) 90 Tablets NDC: 43063-0854-90

Lot numbers, UPCs & expiration codes

Lots: A19B99 Exp. 11/30/2019; B19A26 Exp. 11/30/2019; B19A69 Exp. 11/30/2019; E18F12 Exp.: 09/30/19; F18A12 Exp.: 09/30/19; F18F06 Exp.: 09/30/19; G18B43 Exp.: 09/30/19; G18C43 Exp.: 09/30/19; G18F75 Exp.: 09/30/19; H18D55 Exp.: 09/30/19; I18A11 Exp.: 09/30/19; I18E32 Exp.: 09/30/19; J18A90 Exp.: 09/30/19; J18D50 Exp. 11/30/2019; L18D01 Exp. 11/30/2019

Where it was sold

AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0341-2021
Classification
Class II
Status
Terminated
Recall initiated
Mar 8, 2019
FDA report date
May 5, 2021
Quantity
576 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
PD-Rx Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0341-2021, exactly as published.

Show all FDA fields
City
Oklahoma City
State
OK
Status
Terminated
Country
United States
Event ID
87774
Address
727 N Ann Arbor Ave
Code information
Lots: A19B99 Exp. 11/30/2019; B19A26 Exp. 11/30/2019; B19A69 Exp. 11/30/2019; E18F12 Exp.: 09/30/19; F18A12 Exp.: 09/30/19; F18F06 Exp.: 09/30/19; G18B43 Exp.: 09/30/19; G18C43 Exp.: 09/30/19; G18F75 Exp.: 09/30/19; H18D55 Exp.: 09/30/19; I18A11 Exp.: 09/30/19; I18E32 Exp.: 09/30/19; J18A90 Exp.: 09/30/19; J18D50 Exp. 11/30/2019; L18D01 Exp. 11/30/2019
Postal code
73127-5822
Report date
May 5, 2021
Product type
Drugs
Recall number
D-0341-2021
Classification
Class II
Recalling firm
PD-Rx Pharmaceuticals, Inc.
Product quantity
576 bottles
Termination date
Jun 16, 2021
Reason for recall
CGMP deviation: Product found to contain trace amounts of NMBA
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets NDC: 43063-854-60; b) 90 Tablets NDC: 43063-0854-90
Distribution pattern
AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY
Recall initiation date
Mar 8, 2019
Initial firm notification
Letter
Center classification date
Apr 26, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0341-2021, published May 5, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls